Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
1989-2-16
|
pubmed:abstractText |
Coenzyme Q10 (CoQ10) is indispensable in mitochondrial bioenergetics and for human life to exist. 88/115 patients completed a trial of therapy with CoQ10 for cardiomyopathy. Patients were selected on the basis of clinical criteria, X-rays, electrocardiograms, echocardiography, and coronary angiography. Responses were monitored by ejection fractions, cardiac output, and improvements in functional classifications (NYHA). Of the 88 patients 75%-85% showed statistically significant increases in two monitored cardiac parameters. Patients with the lowest ejection fractions (approx. 10%-30%) showed the highest increases (115 delta %-210 delta %) and those with higher ejection fractions (50%-80%) showed increases of approx. 10 delta %-25 delta % on therapy. By functional classification, 17/21 in class IV, 52/62 in class III, and 4/5 in class II improved to lower classes. Clinical responses appeared over variable times, and are presumably based on mechanisms of DNA-RNA-protein synthesis of apoenzymes which restore levels of CoQ10 enzymes in a deficiency state. 10/21 (48%) of patients in class IV, 26/62 (42%) in class III, and 2/5 (40%) in class II had exceptionally low control blood levels of CoQ10. Clinical responses on therapy with CoQ10 appear maximal with blood levels of approx. 2.5 micrograms CoQ10/ml and higher during therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0023-2173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
583-90
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3062263-Adult,
pubmed-meshheading:3062263-Aged,
pubmed-meshheading:3062263-Aged, 80 and over,
pubmed-meshheading:3062263-Cardiac Output,
pubmed-meshheading:3062263-Cardiomyopathies,
pubmed-meshheading:3062263-Cardiomyopathy, Dilated,
pubmed-meshheading:3062263-Clinical Trials as Topic,
pubmed-meshheading:3062263-Coenzymes,
pubmed-meshheading:3062263-Coronary Disease,
pubmed-meshheading:3062263-Female,
pubmed-meshheading:3062263-Heart Failure,
pubmed-meshheading:3062263-Humans,
pubmed-meshheading:3062263-Male,
pubmed-meshheading:3062263-Middle Aged,
pubmed-meshheading:3062263-Stroke Volume,
pubmed-meshheading:3062263-Ubiquinone
|
pubmed:year |
1988
|
pubmed:articleTitle |
Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
|
pubmed:affiliation |
Department of Medicine, Scott and White Clinic, Temple, Texas.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|